Distribution of Syncopal Eventsfor all Uprima® Studies

Dose

Fixed Dose

Dose-Optimization

2 mg 0.2% (2/964) N/A

4 mg 1.2% (7/590) 0.6% (4/690)

5 mg 0.8% (7/860) 1.1% (6/556)

6 mg 2.1% (13/621) 0.3% (2/631)

Recommended Doses

Higher Than Recommended Doses

Safety-Syncope

Previous slide

Next slide

Back to first slide

View graphic version